Johannes Schoen on the EU Falsified Medicines Directive, Weak Links & Top Tips for Improving Supply Chain Visibility
Add bookmark
Johannes Schoen on the EU Falsified Medicines Directive, Weak Links & Top Tips for Improving Supply Chain Visibility
Add bookmarkIn this interview Johannes Schoen, Senior Manager, Anti-Counterfeiting at Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about the key uncertainties surrounding pharmaceutical serialisation and the impact recent serialisation initiatives will have on the pharma industry. Schoen also shares his thoughts on the implications the EU directive on falsified medicines will have the generics market and his top tips for improving supply chain visibility.
[inlinead]
| Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
anti-counterfeiting strategies
EU Falsified Medicines Directive
supply chain visbility
supply chain integrity
supply chain
biopharma supply chain
Cool Chain Logistics Europe 2013
Johannes Schoen
Boehringer Ingelheim
